Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with β3 integrin
Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with β3 integrin
复制标题
源自 E 蛋白的肽 P4 和 P7 通过与 β3 整合素相互作用抑制登革热病毒血清型 2 的进入
DOI:
10.1016/j.antiviral.2018.04.018
复制
发表时间:
2018-07-01
影响因子:
7.6
通讯作者:
An, Jing
中科院分区:
文献类型:
--
作者:
Cui, Xiaoyun;Wu, Yanhua;An, Jing
Dengue virus (DENV) infection has become a severe public health problem worldwide. However, there is no specific antiviral drug available yet. In this study, we found that DENV serotype 2 (DENV2) infection enhanced the expression of beta 3 integrin on human umbilical vein endothelial cells (HUVECs) and that DENV2 antigens co localized with beta 3 integrin. DENV2 envelope protein (E) directly interacted with beta 3 integrin, and their interacting sites were located at domain III of E protein (EDIII). Several synthetic peptides were designed based on the amino acid sequence of EDIII, and peptides P4 and P7 could inhibit DENV2 entry into HUVECs in a dose-dependent manner. The inhibitory concentration (IC50) of the two peptides was 19.08 +/- 2.52 mu M for P4 and 12.86 +/- 5.96 mu M for P7. Moreover, P7 containing an PG-loop, but not P4, could also inhibit DENV1 entry into HUVECs. Our results suggest a novel mechanism in which interaction between beta 3 integrin and EDIII is involved in DENV entry. The findings on the inhibitory effect of the peptides on viral entry have significance for anti-DENV drug design.